I've been wait­ing for the big show­down be­tween drug­mak­ers and com­pounders for months, and it's fi­nal­ly here. To­day on Post-Hoc Live at 12 p. m. ET, we'll be talk­ing about tele­health com­pa­ny Hims & Her­s' plan to start sell­ing a low­er-cost, com­pound­ed ver­sion of No­vo Nordisk's an­ti-obe­si­ty pill, which the drug­mak­er launched ear­li­er this year...